Credo

Credo

Automated medical record retrieval platform

About Credo

Simplify's Rating
Why Credo is rated
B-
Rated C on Competitive Edge
Rated B on Growth Potential
Rated B on Rating Differentiation

Industries

Enterprise Software

Healthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$8M

Headquarters

Sacramento, California

Founded

2021

Overview

Credo Health provides an automated platform for retrieving medical records, aimed at healthcare providers and insurance payers. The platform uses digital automation to streamline the process of obtaining patient medical records, which reduces the risks and costs associated with manual retrieval. By adhering to new interoperability standards, Credo Health ensures that healthcare staff can access comprehensive patient records quickly, allowing them to concentrate on patient care rather than administrative duties. This leads to better compliance, enhanced clinical understanding, and improved patient outcomes. Unlike competitors, Credo Health focuses on delivering complete and accurate medical records before the first patient visit, enabling informed medical decisions from the outset. The company's goal is to enhance care delivery and patient satisfaction through efficient access to medical information.

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased FHIR adoption enhances Credo's platform capabilities for data exchange.
  • The rise of telehealth boosts demand for Credo's digital record retrieval systems.
  • Shift towards value-based care emphasizes the need for comprehensive patient data.

What critics are saying

  • Emerging competitors may erode Credo's market share with similar platforms.
  • Rapid tech advancements could render Credo's platform obsolete without innovation.
  • Data privacy concerns could undermine trust in Credo's secure retrieval solutions.

What makes Credo unique

  • Credo automates medical record retrieval, reducing manual effort and improving efficiency.
  • The platform leverages interoperability standards for seamless data exchange in healthcare.
  • Credo's Predx solution provides pre-encounter patient summaries, enhancing diagnostic accuracy.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$8M

Above

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$5.3M
Credo

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↓ -3%
PRWeb
Jan 5th, 2024
Credo Health Announces Oversubscribed $5.25 Million Series Seed Funding

"This investment is a testament to our commitment to fully support providers with the technology they need to succeed in value-based care," says Credo Founder and CEO Carm Huntress. .

PRWeb
Mar 27th, 2023
Credo Unveils Predx - The First Pre-Encounter Patient Summary Solution

Our solution not only improves patient outcomes, but directly affects providers' ability to accurately diagnose complex patients and speed up time to effective treatment. .

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Credo right now.

Find jobs on Simplify and start your career today

πŸ’‘
We update Credo's jobs every 8 hours, so check again soon! Browse all jobs β†’